Diana Schenkwein

Senior Researcher , A.I. Virtanen Institute for Molecular Sciences

GeneCellNano Flagship

01.07.2020 - 31.12.2024
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
<...

Vascular Biology (Laakkonen)

'From basic science to translational impact.'
The goal of our junior research group is to improve therapeutics and diagnostics of cardiovascular diseases by understanding the biology behind the diseases. The main focus is in studying vascular anomalies and aortic aneurysms. Particularly ...